Axon Enterprise (NASDAQ:AXON – Free Report) had its price objective boosted by JPMorgan Chase & Co. from $285.00 to $330.00 in a research note released on Wednesday morning, Benzinga reports. The brokerage currently has an overweight rating on the biotechnology company’s stock. AXON has been the subject of several other research reports. TheStreet raised shares […]